For example, MacDiarmid et al. modified minicells using antibodies that enabled the minicells to target epidermal growth factor receptors (EGFR) or human epidermal growth factor receptor 2 (HER2) receptors that are specifically overexpressed on tumor cell membranes. This evidence concerns the gene ERBB2 and neoplasm.